Claim overpayments are a significant contributor to the rising costs of healthcare, with claim error rates for commercial, Medicare fee-for-service (FFS) and Medicaid FFS claims estimated to be a market opportunity in excess of USD 150bn, said healthcare investment banking at Berkery Noyes.